N-Terminal Pro-B-Type Natriuretic Peptide Is a Predictor of Chronic Kidney Disease in an Asian General Population　― The Ohasama Study ―-Reference-Cited by-同舟云学术

N-Terminal Pro-B-Type Natriuretic Peptide Is a Predictor of Chronic Kidney Disease in an Asian General Population　― The Ohasama Study ―

Published:2020-01-10 Issue:1 Volume:2 Page:24-32
ISSN:2434-0790
Container-title:Circulation Reports
language:en
Short-container-title:Circ Rep

Author:

Nakayama Shingo¹²³⁴,Satoh Michihiro³,Metoki Hirohito³⁵,Murakami Takahisa³⁶,Asayama Kei⁵⁷,Hara Azusa⁸,Hirose Takuo²,Inoue Ryusuke⁹,Tsubota-Utsugi Megumi¹⁰,Kikuya Masahiro⁷,Mori Takefumi²,Hozawa Atsushi⁴,Node Koichi¹¹,Imai Yutaka⁵,Ohkubo Takayoshi⁵⁷

Affiliation:

1. Department of Nephrology, Japan Self-Defense Forces Sendai Hospital

2. Division of Nephrology and Endocrinology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University

3. Division of Public Health, Hygiene and Epidemiology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University

4. Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University

5. Tohoku Institute for Management of Blood Pressure

6. Division of Aging and Geriatric Dentistry, Department of Oral Function and Morphology, Tohoku University Graduate School of Dentistry

7. Department of Hygiene and Public Health, Teikyo University School of Medicine

8. Department of Social Pharmacy and Public Health, Showa Pharmaceutical University

9. Medical Information Technology Center, Tohoku University Hospital

10. Department of Hygiene and Preventive Medicine, Iwate Medical University School of Medicine

11. Department of Cardiovascular Medicine, Saga University

Publisher

Japanese Circulation Society

Subject

Marketing,Organizational Behavior and Human Resource Management,Strategy and Management,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.jstage.jst.go.jp/article/circrep/2/1/2_CR-19-0044/_pdf

Reference41 articles.

1. 1. Xie Y, Bowe B, Mokdad AH, Xian H, Yan Y, Li T, et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int 2018; 94: 567–581.

2. 2. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154–2169.

3. 3. Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Doi Y, Okubo K, et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: The Hisayama Study. Kidney Int 2005; 68: 228–236.

4. 4. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321–328.

5. 5. Martinez-Rumayor A, Richards AM, Burnett JC, Januzzi JL Jr. Biology of the natriuretic peptides. Am J Cardiol 2008; 101: 3–8.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma B-type natriuretic peptide is independently associated with cardiovascular events and mortality in patients with chronic kidney disease;Scientific Reports;2024-07-17

2. Plasma B-type natriuretic peptide is independently associated with cardiovascular events and mortality in patients with chronic kidney disease;2024-04-05

3. Changes in Natriuretic Peptide Levels and Subsequent Kidney Function Decline in SPRINT;American Journal of Kidney Diseases;2023-11

4. Predictive Value of N-Terminal Pro B-Type Natriuretic Peptide for Contrast-Induced Nephropathy Non-Recovery and Poor Outcomes Among Patients Undergoing Percutaneous Coronary Intervention;Circulation Journal;2023-01-25

5. Actual impact of angiotensin II receptor blocker or calcium channel blocker monotherapy on renal function in real-world patients;Journal of Hypertension;2022-07-05